These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

713 related items for PubMed ID: 10389982

  • 1. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
    Sartor M, Steingrimsdottir H, Elamin F, Gäken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M.
    Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
    [Abstract] [Full Text] [Related]

  • 2. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K, Reed AL, Cairns P, Koch WM, Westra WH, Wehage S, Jen J, Sidransky D.
    Oncogene; 1999 Jun 10; 18(23):3541-5. PubMed ID: 10376532
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.
    Lai S, El-Naggar AK.
    Lab Invest; 1999 Mar 10; 79(3):255-60. PubMed ID: 10092061
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
    Geradts J, Kratzke RA, Niehans GA, Lincoln CE.
    Cancer Res; 1995 Dec 15; 55(24):6006-11. PubMed ID: 8521382
    [Abstract] [Full Text] [Related]

  • 5. Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas.
    Park HW, Song SY, Lee TJ, Jeong D, Lee TY.
    Oncol Rep; 2007 Jul 15; 18(1):267-72. PubMed ID: 17549378
    [Abstract] [Full Text] [Related]

  • 6. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
    Takeuchi H, Ozawa S, Ando N, Shih CH, Koyanagi K, Ueda M, Kitajima M.
    Clin Cancer Res; 1997 Dec 15; 3(12 Pt 1):2229-36. PubMed ID: 9815619
    [Abstract] [Full Text] [Related]

  • 7. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H.
    Cancer Res; 1997 Oct 15; 57(20):4608-14. PubMed ID: 9377576
    [Abstract] [Full Text] [Related]

  • 8. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
    Havrilesky LJ, Alvarez AA, Whitaker RS, Marks JR, Berchuck A.
    Gynecol Oncol; 2001 Dec 15; 83(3):491-500. PubMed ID: 11733961
    [Abstract] [Full Text] [Related]

  • 9. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
    Huang L, Lang D, Geradts J, Obara T, Klein-Szanto AJ, Lynch HT, Ruggeri BA.
    Mol Carcinog; 1996 Feb 15; 15(2):85-95. PubMed ID: 8599583
    [Abstract] [Full Text] [Related]

  • 10. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
    Mishra R, Das BR.
    Arch Oral Biol; 2009 Oct 15; 54(10):917-23. PubMed ID: 19679297
    [Abstract] [Full Text] [Related]

  • 11. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 12. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
    Soni S, Kaur J, Kumar A, Chakravarti N, Mathur M, Bahadur S, Shukla NK, Deo SV, Ralhan R.
    Oncology; 2005 Jan 01; 68(4-6):314-25. PubMed ID: 16020958
    [Abstract] [Full Text] [Related]

  • 13. Cell cycle-related gene abnormalities and product expression in esophageal carcinoma.
    Roncalli M, Bosari S, Marchetti A, Buttitta F, Bossi P, Graziani D, Peracchia A, Bonavina L, Viale G, Coggi G.
    Lab Invest; 1998 Sep 01; 78(9):1049-57. PubMed ID: 9759649
    [Abstract] [Full Text] [Related]

  • 14. HPV infection and the alterations of the pRB pathway in oral carcinogenesis.
    Lim KP, Hamid S, Lau SH, Teo SH, Cheong SC.
    Oncol Rep; 2007 Jun 01; 17(6):1321-6. PubMed ID: 17487385
    [Abstract] [Full Text] [Related]

  • 15. Ovarian cancer cells that coexpress endogenous Rb and p16 are insensitive to overexpression of functional p16 protein.
    Todd MC, Sclafani RA, Langan TA.
    Oncogene; 2000 Jan 13; 19(2):258-64. PubMed ID: 10645004
    [Abstract] [Full Text] [Related]

  • 16. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S, Mihara M, Nakahara Y, Kiyota A, Yoshihama Y, Ueyama Y, Matsumura T.
    Anticancer Res; 2000 Jan 13; 20(3B):2169-75. PubMed ID: 10928172
    [Abstract] [Full Text] [Related]

  • 17. [Changes of p16 gene, cyclin D1 gene, and pRb protein in human pancreatic adenocarcinoma cell lines].
    Xu Y, Chen J, Liu T, Gu L, Gao J, Li L.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Dec 13; 22(6):566-9. PubMed ID: 12903406
    [Abstract] [Full Text] [Related]

  • 18. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
    Chatterjee SJ, George B, Goebell PJ, Alavi-Tafreshi M, Shi SR, Fung YK, Jones PA, Cordon-Cardo C, Datar RH, Cote RJ.
    J Pathol; 2004 Jul 13; 203(3):762-70. PubMed ID: 15221935
    [Abstract] [Full Text] [Related]

  • 19. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES.
    Laryngoscope; 2002 Mar 13; 112(3):472-81. PubMed ID: 12148857
    [Abstract] [Full Text] [Related]

  • 20. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.
    Hsu LC, Huang X, Seasholtz S, Potter DM, Gollin SM.
    Oncogene; 2006 Sep 07; 25(40):5517-26. PubMed ID: 16619035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.